Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.

Neurology - 17 Apr 2018

Hara Makoto, Martinez-Hernandez Eugenia, Ariño Helena, Armangué Thais, Spatola Marianna, Petit-Pedrol Mar, Saiz Albert, Rosenfeld Myrna R, Graus Francesc, Dalmau Josep

Abstract excerpt

OBJECTIVE: To determine the frequency and clinical relevance of immunoglobulin (Ig)G, IgA, and IgM N-methyl-d-aspartate receptor (NMDAR) antibodies in several diseases, and whether the IgG antibodies occur in disorders other than anti-NMDAR encephalitis. METHODS: Evaluation of IgG, IgA, and IgM NMDAR antibodies in serum of 300 patients with anti-NMDAR encephalitis, stroke, dementia, schizophrenia, or seronegative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Dementia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulin A

Share to Immunoglobulin G

Share to Immunoglobulin M

Share to Positron-Emission Tomography

Share to Receptors, N-Methyl-D-Aspartate

Share to Stroke

Source

Open in PubMed Open full text

Identifiers

PMID: 29549218
DOI: 10.1212/WNL.0000000000005329
PMCID: PMC5902781

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.PMID 29549218Read ↗

Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases.Semantic proximity Read ↗

Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous SystemSemantic proximity Read ↗

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.Semantic proximity Read ↗

Autoimmune EncephalitisSemantic proximity Read ↗

Clinical analysis of MOG antibody-associated disease overlapped with anti-NMDA receptor encephalitis: a long-term retrospective studySemantic proximity Read ↗

All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin classSemantic proximity Read ↗

Neuronal central nervous system syndromes probably mediated by autoantibodiesSemantic proximity Read ↗

NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical FeaturesSemantic proximity Read ↗

Encephalitis and antibodies to synaptic and neuronal cell surface proteinsSemantic proximity Read ↗

Differences and diversity of autoimmune-mediated encephalitis in 77 cases from a single tertiary care centerSemantic proximity Read ↗

Anti-NMDA Receptor Encephalitis Following SARS-CoV-2 Infection: A Systematic Review and Pooled Case SeriesSemantic proximity Read ↗

Identification and Characterization of GABAA Receptor Autoantibodies in Autoimmune EncephalitisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.